What Happened?
Irvine, CA-based Novus-Therapeutics Appointed David Gros as Chief Executive Officer and Director
About the Company
Novus Therapeutics, Inc. (NASDAQ: NVUS) is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease.
About the Person
David Gros is Chief Executive Officer and Director at Novus Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile